Type I Interferon in COVID-19

Brief description of study

The purpose of this research study is to look at the genes (DNA) and biomarkers in the blood of patients that test COVID-positive or are COVID-19 negative. The COVID-19 infection presents differently between children and adults, and it ranges from asymptomatic to pernio-like lesions known as “COVID toes” to acute respiratory distress (ARDS) and death. Having a better understanding of these biomarkers and the factors that lead to severe COVID-19 infection is important as it can improve current public health efforts and inform novel treatment and prevention strategies. Subjects who do not have COVID-19 (healthy controls) will also be asked to participate. Their biomarkers and genetic makeup will be compared to those COVID-19 positive patients to find potential differences that may help us better understand the factors that influence severity.


Clinical Study Identifier: s20-00843
Principal Investigator: Timothy Niewold.


Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.